Immunotherapy for Metastatic Kidney Cancer Shows Increased Survival
2 Visualizações
administrator
07/10/23
The immune checkpoint inhibitor Opdivo (nivolumab) has been shown to increase survival for patients with metastatic clear cell kidney cancer (also called renal cell carcinoma, or RCC).
Mostre mais
Comentários do Facebook
Nenhum comentário encontrado